Literature DB >> 17660950

Inhibition of cytosolic and mitochondrial creatine kinase by siRNA in HaCaT- and HeLaS3-cells affects cell viability and mitochondrial morphology.

Holger Lenz1, Melanie Schmidt, Vivienne Welge, Thomas Kueper, Uwe Schlattner, Theo Wallimann, Hans-Peter Elsässer, Klaus-Peter Wittern, Horst Wenck, Franz Staeb, Thomas Blatt.   

Abstract

The creatine kinase (CK) system is essential for cellular energetics in tissues or cells with high and fluctuating energy requirements. Creatine itself is known to protect cells from stress-induced injury. By using an siRNA approach to silence the CK isoenzymes in human keratinocyte HaCaT cells, expressing low levels of cytoplasmic CK and high levels of mitochondrial CK, as well as HeLa cancer cells, expressing high levels of cytoplasmic CK and low levels of mitochondrial CK, we successfully lowered the respective CK expression levels and studied the effects of either abolishing cytosolic brain-type BB-CK or ubiquitous mitochondrial uMi-CK in these cells. In both cell lines, targeting the dominant CK isoform by the respective siRNAs had the strongest effect on overall CK activity. However, irrespective of the expression level in both cell lines, inhibition of the mitochondrial CK isoform generally caused the strongest decline in cell viability and cell proliferation. These findings are congruent with electron microscopic data showing substantial alteration of mitochondrial morphology as well as mitochondrial membrane topology after targeting uMi-CK in both cell lines. Only for the rate of apoptosis, it was the least expressed CK present in each of the cell lines whose inhibition led to the highest proportion of apoptotic cells, i.e., downregulation of uMi-CK in case of HeLaS3 and BB-CK in case of HaCaT cells. We conclude from these data that a major phenotype is linked to reduction of mitochondrial CK alone or in combination with cytosolic CK, and that this effect is independent of the relative expression levels of Mi-CK in the cell type considered. The mitochondrial CK isoform appears to play the most crucial role in maintaining cell viability by stabilizing contact sites between inner and outer mitochondrial membranes and maintaining local metabolite channeling, thus avoiding transition pore opening which eventually results in activation of caspase cell-death pathways.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17660950     DOI: 10.1007/s11010-007-9565-8

Source DB:  PubMed          Journal:  Mol Cell Biochem        ISSN: 0300-8177            Impact factor:   3.396


  46 in total

1.  Creatine and cyclocreatine attenuate MPTP neurotoxicity.

Authors:  R T Matthews; R J Ferrante; P Klivenyi; L Yang; A M Klein; G Mueller; R Kaddurah-Daouk; M F Beal
Journal:  Exp Neurol       Date:  1999-05       Impact factor: 5.330

2.  Protective effects of oral creatine supplementation on spinal cord injury in rats.

Authors:  O N Hausmann; K Fouad; T Wallimann; M E Schwab
Journal:  Spinal Cord       Date:  2002-09       Impact factor: 2.772

Review 3.  Mitochondrial creatine kinase in human health and disease.

Authors:  Uwe Schlattner; Malgorzata Tokarska-Schlattner; Theo Wallimann
Journal:  Biochim Biophys Acta       Date:  2005-09-27

4.  The role of creatine kinase in inhibition of mitochondrial permeability transition.

Authors:  E O'Gorman; G Beutner; M Dolder; A P Koretsky; D Brdiczka; T Wallimann
Journal:  FEBS Lett       Date:  1997-09-08       Impact factor: 4.124

5.  Long-term creatine intake is beneficial to muscle performance during resistance training.

Authors:  K Vandenberghe; M Goris; P Van Hecke; M Van Leemputte; L Vangerven; P Hespel
Journal:  J Appl Physiol (1985)       Date:  1997-12

6.  Protective effect of the energy precursor creatine against toxicity of glutamate and beta-amyloid in rat hippocampal neurons.

Authors:  G J Brewer; T W Wallimann
Journal:  J Neurochem       Date:  2000-05       Impact factor: 5.372

7.  Inhibition of the mitochondrial permeability transition by creatine kinase substrates. Requirement for microcompartmentation.

Authors:  Max Dolder; Bernd Walzel; Oliver Speer; Uwe Schlattner; Theo Wallimann
Journal:  J Biol Chem       Date:  2003-03-05       Impact factor: 5.157

8.  Changes in mRNA expression profile underlie phenotypic adaptations in creatine kinase-deficient muscles.

Authors:  A J de Groof; B Smeets; M J Groot Koerkamp; A N Mul; E E Janssen; H F Tabak; B Wieringa
Journal:  FEBS Lett       Date:  2001-09-28       Impact factor: 4.124

9.  Structural and behavioural consequences of double deficiency for creatine kinases BCK and UbCKmit.

Authors:  Femke Streijger; Frank Oerlemans; Bart A Ellenbroek; Carolina R Jost; Bé Wieringa; Catharina E E M Van der Zee
Journal:  Behav Brain Res       Date:  2005-02-28       Impact factor: 3.332

10.  Dietary supplement creatine protects against traumatic brain injury.

Authors:  P G Sullivan; J D Geiger; M P Mattson; S W Scheff
Journal:  Ann Neurol       Date:  2000-11       Impact factor: 10.422

View more
  7 in total

1.  Mitochondrial creatine kinase interaction with cardiolipin-containing biomimetic membranes is a two-step process involving adsorption and insertion.

Authors:  Ofelia Maniti; Marie-France Lecompte; Olivier Marcillat; Christian Vial; Thierry Granjon
Journal:  Eur Biophys J       Date:  2010-04-02       Impact factor: 1.733

2.  Unchanged mitochondrial organization and compartmentation of high-energy phosphates in creatine-deficient GAMT-/- mouse hearts.

Authors:  Jelena Branovets; Mervi Sepp; Svetlana Kotlyarova; Natalja Jepihhina; Niina Sokolova; Dunja Aksentijevic; Craig A Lygate; Stefan Neubauer; Marko Vendelin; Rikke Birkedal
Journal:  Am J Physiol Heart Circ Physiol       Date:  2013-06-21       Impact factor: 4.733

3.  ASB9 interacts with ubiquitous mitochondrial creatine kinase and inhibits mitochondrial function.

Authors:  Sanghoon Kwon; Dongbum Kim; Jae Won Rhee; Jeong-A Park; Dae-Won Kim; Doo-Sik Kim; Younghee Lee; Hyung-Joo Kwon
Journal:  BMC Biol       Date:  2010-03-19       Impact factor: 7.431

4.  Mitochondrial creatine kinase binding to phospholipid monolayers induces cardiolipin segregation.

Authors:  Ofelia Maniti; Marie-France Lecompte; Olivier Marcillat; Bernard Desbat; René Buchet; Christian Vial; Thierry Granjon
Journal:  Biophys J       Date:  2009-03-18       Impact factor: 4.033

5.  Proteomic analysis of rat brain mitochondria following exposure to dopamine quinone: implications for Parkinson disease.

Authors:  Victor S Van Laar; April A Dukes; Michael Cascio; Teresa G Hastings
Journal:  Neurobiol Dis       Date:  2007-11-28       Impact factor: 5.996

6.  Increasing creatine kinase activity protects against hypoxia / reoxygenation injury but not against anthracycline toxicity in vitro.

Authors:  Sevasti Zervou; Hannah J Whittington; Philip J Ostrowski; Fang Cao; Jack Tyler; Hannah A Lake; Stefan Neubauer; Craig A Lygate
Journal:  PLoS One       Date:  2017-08-14       Impact factor: 3.240

7.  Phosphocreatine interacts with phospholipids, affects membrane properties and exerts membrane-protective effects.

Authors:  Malgorzata Tokarska-Schlattner; Raquel F Epand; Flurina Meiler; Giorgia Zandomeneghi; Dietbert Neumann; Hans R Widmer; Beat H Meier; Richard M Epand; Valdur Saks; Theo Wallimann; Uwe Schlattner
Journal:  PLoS One       Date:  2012-08-17       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.